People with schizophrenia who participate in clinical trials may not be representative of the population suffering from this disease.
People with schizophrenia who participate in clinical trials may not be representative of the population suffering from this disease. https://www.tauli.cat/institut/wp-content/uploads/2022/02/NDP_Estudio-clinico-esquizofrenia-1200x900.jpg 1080 810 Mireia Córcoles https://www.tauli.cat/institut/wp-content/uploads/2022/11/Tezza-0184-150x150.jpg
An international study, co-sponsored by I3PT, shows that clinical trials can account for only about one-fifth of people in the real world with schizophrenia spectrum disorders.
read more